Infectious Disease

Nonmodifiable factors predict treatment success for peri-prosthetic joint infections

February 22, 2022

2 min read

Source/Disclosures

Published by:

infectious disease news logo

Disclosures:
The authors report no relevant financial disclosures.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

Predictors of treatment success in peri-prosthetic joint infections include nonmodifiable factors like the joint where the infection occurred, age of the implant, patient age and comorbidities, and what caused the infection, a study found.

The results of the study, which was conducted at nearly 30 hospitals in Australia and New Zealand, “suggests that debridement and implant retention should be reserved for early post-implant infections, and that matching a patient to the appropriate management strategy is the key role of treating clinicians,” the researchers wrote.

Source: Adobe Stock.

The outcomes of peri-prosthetic joint infections are dependent on several factors. Source: Adobe Stock.

“I am an infectious diseases physician, and a big part of my practice is seeing patients with prosthetic joint infection (PJI),” Joshua S Davis, MBBS, PhD, DTM&H, staff specialist in infectious diseases and general medicine at the John Hunter Hospital in Australia, told Healio. “This is a frustrating condition to treat, as the evidence base informing its management is very poor.”

Joshua S Davis

“What we really need are randomized controlled trials addressing common management questions — for example, what is the best type and duration of antibiotic therapy? What is the best surgical strategy?” Davis said. “However, before we could do that, we wanted to create a network of collaborating sites and investigators, and measure current practice variation and outcomes.”

David and colleagues began the PIANO study, which prospectively enrolled and collected data on 783 patients with PJI at 27 hospitals in Australia and New Zealand between July 2014 and December 2017 making it the largest study of its kind globally.

The data collected at baseline and at 3, 12 and 24 months. The main outcome measures at 24 months were clinical cure and treatment success.

Overall, 24-month outcome data were available for 653 patients in December 2019, of whom 449 (69%) experienced clinical cure and 350 (54%) had treatment success. Davis and colleagues found that the most common treatment strategy was debridement and implant retention, with success rates being the highest among early post-implant infections (74%) and lower in the late acute and chronic infections (49% and 44%, respectively) .

The study also demonstrated that selected variables, such as knee joints — compared with hip joints, for example — and Staphylococcus aureus infection, were independently associated with treatment failure. However, antibiotic choice and duration and the extent of debridement were not.

“The choice of the appropriate surgical strategy — debridement with implant retention, revision or other — is the key determinant of a good outcome, much more so than the type or duration of antibiotic therapy,” Davis said. “Both orthopedic surgeons and infectious diseases physicians should be involved in discussions with the patient to choose the best treatment approach in their specific case.”

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

Related Articles